29 April 2017
News and Views
Links and Services
A study published in the Alimentary Pharmacology & Therapeutics quantifies the safety and efficacy of hyperbaric oxygen therapy for Crohn's disease and ulcerative colitis.
Hyperbaric oxygen therapy (HBOT) provides 100% oxygen under pressure, which increases tissue oxyg
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors